Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Lien

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|November 1, 1992
High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell linesN S Stuart, P Philip, A L Harris, et al.
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Metabolism: Clinical and Experimental|January 24, 1998
Plasma total homocysteine levels in hyperthyroid and hypothyroid patientsB G Nedrebø, U B Ericsson, O Nygård, et al.
European Journal of Endocrinology|April 9, 2015
Novel inflammatory biomarkers in primary hyperparathyroidismM H E Christensen, I S Fenne, Y Nordbø, et al.
Journal of Internal Medicine|October 11, 2003
Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smokingB G Nedrebø, S Hustad, J Schneede, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolismJ Gjerde, M Hauglid, H Breilid, et al.
British Journal of Cancer|September 17, 2009
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitorsM Hauglid Flågeng, L L Haugan Moi, J M Dixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|November 1, 1992
High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell linesN S Stuart, P Philip, A L Harris, et al.
Journal of Thrombosis and Haemostasis : JTH|October 3, 2003
Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Metabolism: Clinical and Experimental|January 24, 1998
Plasma total homocysteine levels in hyperthyroid and hypothyroid patientsB G Nedrebø, U B Ericsson, O Nygård, et al.
European Journal of Endocrinology|April 9, 2015
Novel inflammatory biomarkers in primary hyperparathyroidismM H E Christensen, I S Fenne, Y Nordbø, et al.
Journal of Internal Medicine|October 11, 2003
Homocysteine and its relation to B-vitamins in Graves' disease before and after treatment: effect modification by smokingB G Nedrebø, S Hustad, J Schneede, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2007
Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolismJ Gjerde, M Hauglid, H Breilid, et al.
British Journal of Cancer|September 17, 2009
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitorsM Hauglid Flågeng, L L Haugan Moi, J M Dixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy womenA Decensi, S Gandini, A Guerrieri-Gonzaga, et al.
Breast Cancer Research and Treatment|January 5, 2002
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy womenB Bonanni, H Johansson, S Gandini, et al.
Pageof 5